Company Tests Diabetes Drug As Potential Treatment For COVID-19

reports AstraZeneca Plc is testing its diabetes drug Farxiga (dapagliflozin) as a treatment for COVID-19. However, physicians are advising patients with diabetes who become infected with coronavirus “to stop taking the medicine and others like it because of the” risk of diabetic ketoacidosis. https://www.reuters.com/article/legal-us-health-coronavirus-astrazeneca/astrazeneca-tests-diabetes-drug-for-covid-19-despite-risk-seen-by-doctors-idUSKBN234057